Maternal exposures and NOWS outcomes of the opioid cohort
| Demographic | Mean (SD) or n (%) |
|---|---|
| Maternal OUD treatment | |
| Methadone | 29 (45.3%) |
| Buprenorphine | 35 (54.7%) |
| Dose at delivery (mg/day) | |
| Methadone | 80.5 (35.4) |
| Buprenorphine | 11.4 (6.3) |
| Breastfed | 32 (50.0%) |
| Co-exposures | |
| Nicotine smoking | 44 (47.3%) |
| SSRIs | 1 (1.6%) |
| Benzodiazepines | 7 (11.1%) |
| Illicit drugs | 35 (37.6%) |
| NOWS pharmacologic treatment | 49 (76.6%) |
| Two pharmacologic agents for NOWS | 10 (15.6%) |
| LOS for NOWS (days) | 16.5 (9.7) |
| NOWS morphine treatment days | 12.4 (8.8) |